Disseminated intravascular coagulation.
The diagnosis of disseminated intravascular coagulation associated with intracranial pathology is discussed. This pathological entity is characterized by a diffuse bleeding diathesis. Laboratory studies suggest a consumption of all clotting and fibrinolytic factors with an elevation of fibrin split products as a sign of the fibrinolytic activity. The treatment consists of the administration of packed platelets and fresh frozen plasma to replace the consumed coagulation factors. Heparinization is recommended early to prevent further consumption of coagulation factors and epsilon-aminocaproic acid is recommended later after acute fibrinolysis is diagnosed. Constant coaguloanalytic monitoring is necessary. Although the etiology with massive injury to brain tissue is possibly secondary to autotransfusion of brain tissue thromboplastin, other causes such as hypotension, anoxia, acidosis and hemolysis must be considered.
D001780:Blood Coagulation Tests; D002649:Child Abuse; D004211:Disseminated Intravascular Coagulation / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D006408:Hematoma, Subdural / Q000150:complications*; D006801:Humans; D007223:Infant; D008297:Male